Added to YB: 2025-03-28
Pitch date: 2025-02-09
BHC [bearish]
Bausch Health Companies Inc.
+25.19%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company.
Market Cap
$1.8B
Pitch Price
$6.43
Price Target
N/A
Dividend
N/A
EV/EBITDA
6.00
P/E
-1.51
EV/Sales
2.12
Sector
Pharmaceuticals
Category
turnaround
Show full summary:
Bausch Health Companies Inc. - $BHC
BHC short: Failed BLCO sale eliminates value transfer to equity. Unsustainable leverage (6.2x Net Debt/EBITDA) with $15.3B debt. EBITDA to drop ~40% in 2028 on Xifaxan loss. 2027 $4.1B maturities unmanageable. Restructuring likely by 2027, leaving minimal equity value. Near-term catalysts: 2025 maturities, going concern language.
Read full article (8 min)